hypocritexposer
Well-known member
CHUGAI PHARMACEUTICAL CO., LTD. ANNUAL REPORT 2008
projects Tamiflu sales will increase by 531% in 2009. We'll have to see how all this shakes out, but I bet we're in for a coincidence.
http://www.chugai-pharm.co.jp/pdf/annual_report/2009/eAR2009_12_04.pdf
projects Tamiflu sales will increase by 531% in 2009. We'll have to see how all this shakes out, but I bet we're in for a coincidence.
FY 2009 Outlook
Increased Sales and Income Expected in FY 2009 Due to Higher Sales of Growth Drivers
In FY2009, we expect revenues of ¥400 billion, up 22.4%
year-on-year, driven by further growth of our major
products. We project a 7.6% increase in product sales
excluding Tamiflu to ¥337.3 billion.
For the year, we forecast sales of Tamiflu to reach ¥53.0
billion, up 531.0%, due to expected resumption of government
stockpiling in FY2009 and the ongoing recovery
of the prescription rate for seasonal influenza.
http://www.chugai-pharm.co.jp/pdf/annual_report/2009/eAR2009_12_04.pdf